Jean Sévigny
Chercheur universitaire
Axe Maladies infectieuses et immunitaires
Dernières nouvelles
Voir toutPublications
Voir tout-
article Ouattara AK, Bahrami F, Turcitu RA, Kukulski F, Lecka J, Pelletier J, Espindola Gelsleichter N, Vidal T, Sévigny J
P2Y2 Receptor Controls TLR3-Induced Chemokine Production in Intestinal Epithelial Cells
J Immunol Res 2026 (1), 2026.
-
article da Silva JLG, Sévigny J, Leal DBR
Nucleotide signaling in neutrophils: a key player in cancer dynamics
Purinergic Signal 22 (3), 2026.
-
article Saidi A, Tollard C, Liu L, El Khallouqi Y, Sévigny J, Auger C, Kauffenstein G, Ghazouani FE, Kessler L, Toti F
New Islet Model for 3D Study of Endothelial and β Cell Interactions: Relevance for the Screening of Cytoprotective Agents
J Vis Exp (230), 2026.
Projets
- Ectonucleotidases and Extracellular Nucleotides in Smooth Muscle Cell Contraction, du 2023-04-01 au 2028-03-31
- Regroupement Québécois de Recherche sur la Fonction, l’Ingénierie et les Applications des Protéines, du 2024-04-01 au 2030-03-31
- A recombinant soluble NTPDase8 as a novel biological treatment for inflammatory bowel disease, du 2021-10-01 au 2026-09-30
- Novel P2Y6 antagonists as a potential therapy for inflammatory bowel disease, du 2021-07-01 au 2025-06-30
- Initial biophysical analysis of the NTPDase3 antibody binding site to NTPDase3 and preparation of antibodies, du 2025-07-22 au 2026-07-21
- Development and characterization of K. PHAFFII apyrases for research and inflammation control, du 2025-04-01 au 2026-03-31